It is supposed to stop tumor growth and prevent metastasis: Russia claims to have developed an anti-cancer vaccine

Vladimir Poutine a annoncé en début d'année que la Russie était sur le point de développer des vaccins contre le cancer de “nouvelle génération”. MAXPPP – IMAGO/Gavriil Grigorov

Russia has reportedly developed an anti-cancer vaccine, leading Russian oncologist Andrey Kaprin announced early last week.

Russian oncologist Andrey Kaprin announced this early last week on “Radio Rossiya”, Russia's main public radio station.

200% Deposit Bonus up to €3,000 180% First Deposit Bonus up to $20,000

“Suppressing tumor growth and preventing metastases”

The oncologist, who is also the director of the Research Center for Radiology, which is part of the Russian Ministry of Health, announced that Russia had developed an anti-cancer vaccine.

The result of a collaboration between several research institutes, this vaccine should be marketed at the beginning of 2025 and will be completely free, according to the Russian oncologist and the Russian news agency TASS.

It would have been developed on the basis of mRNA technology, like the vaccines against the coronavirus. This anti-cancer vaccine would thus make it possible to “suppress the growth of a tumor and prevent metastases,” explained Andrey Kaprin on the radio “Radio Rossiya”.

“It is impossible that this is a universal vaccine”

Earlier this year, Vladimir Putin, the Russian president, announced that Russia was on the verge of developing “new generation” cancer vaccines.

Despite Moscow's enthusiastic announcement, Western scientists remain skeptics: “Until we see the results of clinical trials, we should remain skeptical,”, Professor Kingston Mills told Newsweek magazine.

For the immunologist at Trinity College in Ireland, given the multiple forms of cancer, it is “impossible that this is a universal vaccine”, he explained.

And to conclude: “What type of cancer is it? ? Where are the data from clinical trials? ? These are questions that need to be answered to evaluate these claims.”